NI
Nextech Invest, Ltd.
Concentrated strategySector-focusedMomentum follower
Total reported value
$1.4B
Reporting period: 2026-03-31 · Number of holdings: 17
Nextech Invest, Ltd. disclosed 17 holdings in its latest 13F filing for the period ending 2026-03-31, with total reported value of $1.4B and a quarterly turnover rate of 35.2%.
Personality snowflake
- Concentration
- 100
- Portfolio Stability
- 35.24
- Momentum/Contrarian
- 100
- Sector conviction
- 100
- Diversification
- 34
- Sizing Uniformity
- 78.96
Recent moves
Trim RVMD
0.0% $133.8M
Add TNGX
0.0% $87.6M
Add ALMS
+21.4% $49.5M
Trim ZYME
0.0% -$1.4M
Trim 29286M105
+9.4% -$3.4M
Add ORIC
0.0% $32.2M
Holdings Map
New buyAddUnchangedTrim
Top 10 holdings by weight
Full holdings list this quarter
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | RVMD | Revolution Medicines INC | Stock-Healthcare | 52.02% | -6.51% | — | |
| 2 | TYRA | Tyra Biosciences INC | Stock-Other | 10.93% | +0.62% | — | |
| 3 | TNGX | Tango Therapeutics INC | Stock-Other | 10.70% | +4.48% | — | |
| 4 | ORIC | Oric Pharmaceuticals INC | Stock-Other | 6.39% | +0.73% | — | |
| 5 | ALMS | Alumis INC | Stock-Other | 5.49% | +2.74% | +21.43% | |
| 6 | RLAY | Relay Therapeutics INC | Stock-Other | 3.87% | +0.02% | +17.55% | |
| 7 | ZYME | Zymeworks INC | Stock-Other | 1.96% | -0.88% | — | |
| 8 | KYMR | Kymera Therapeutics INC | Stock-Other | 1.63% | -0.47% | — | |
| 9 | CTMX | Cytomx Therapeutics INC | Stock-Other | 1.47% | +1.47% | NEW | |
| 10 | CNTX | Context Therapeutics INC | Stock-Other | 1.37% | +0.32% | — | |
| 11 | CGEM | Cullinan Therapeutics INC | Stock-Other | 1.14% | — | — | |
| 12 | ✓ | Engene Holdings INC | Stock-Other | 1.11% | -0.75% | +9.41% | |
| 13 | CRVS | Corvus Pharmaceuticals INC | Stock-Other | 0.46% | +0.46% | NEW | |
| 14 | ARVN | Arvinas INC | Stock-Other | 0.40% | -0.22% | — | |
| 15 | SLN | Silence Therapeutics Plc-adr | Stock-Other | 0.35% | -0.21% | — | |
| 16 | GLUE | Monte Rosa Therapeutics INC | Stock-Other | 0.35% | -0.07% | +8.95% | |
| 17 | SPRY | Ars Pharmaceuticals INC | Stock-Other | 0.35% | -0.39% | -7.57% |
Reported value over time
Sector allocation
Sector allocation over time
Quarterly history
Holding changes this quarter
Nextech Invest, Ltd.'s most significant position changes for 2026-03-31: New buy: Cytomx Therapeutics INC (CTMX); Sold out: Mersana Therapeutics INC (MRSN); New buy: Corvus Pharmaceuticals INC (CRVS); Add: Alumis INC (ALMS) — shares +21.43%; Add: Engene Holdings INC — shares +9.41%.
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | TNGX | Tango Therapeutics INC | +4.5% | — | Unchanged |
| 2 | ALMS | Alumis INC | +2.7% | +21.43% | Add |
| 3 | ORIC | Oric Pharmaceuticals INC | +0.7% | — | Unchanged |
| 4 | TYRA | Tyra Biosciences INC | +0.6% | — | Unchanged |
| 5 | CNTX | Context Therapeutics INC | +0.3% | — | Unchanged |
| 6 | RLAY | Relay Therapeutics INC | 0% | +17.55% | Add |
| 7 | CGEM | Cullinan Therapeutics INC | — | — | Unchanged |
| 8 | GLUE | Monte Rosa Therapeutics INC | -0.1% | +8.95% | Add |
| 9 | SLN | Silence Therapeutics Plc-adr | -0.2% | — | Unchanged |
| 10 | ARVN | Arvinas INC | -0.2% | — | Unchanged |
| 11 | SPRY | Ars Pharmaceuticals INC | -0.4% | -7.57% | Trim |
| 12 | KYMR | Kymera Therapeutics INC | -0.5% | — | Unchanged |
| 13 | ✓ | Engene Holdings INC | -0.8% | +9.41% | Add |
| 14 | ZYME | Zymeworks INC | -0.9% | — | Unchanged |
| 15 | RVMD | Revolution Medicines INC | -6.5% | — | Unchanged |
| 16 | CTMX | Cytomx Therapeutics INC | — | NEW | New buy |
| 17 | MRSN | Mersana Therapeutics INC | — | EXIT | Sold out |
| 18 | CRVS | Corvus Pharmaceuticals INC | — | NEW | New buy |
FAQ
What is Nextech Invest, Ltd. and what type of investor is it?
Nextech Invest, Ltd. is a investment manager that files SEC Form 13F quarterly, disclosing its U.S. public equity holdings to regulators. As of the most recent reporting period (2026-03-31), the firm manages a tracked equity portfolio valued at approximately $1.4B, spread across 17 disclosed positions.
What are Nextech Invest, Ltd.'s largest equity positions?
Based on the latest 13F filing, Nextech Invest, Ltd.'s top holdings by market value are:
1. Revolution Medicines INC (RVMD) — $739.2M (52.0%)
2. Tyra Biosciences INC (TYRA) — $155.3M (10.9%)
3. Tango Therapeutics INC (TNGX) — $152.0M (10.7%)
4. Oric Pharmaceuticals INC (ORIC) — $90.8M (6.4%)
5. Alumis INC (ALMS) — $78.0M (5.5%)
What changes did Nextech Invest, Ltd. make in its most recent portfolio filing?
In the latest reported quarter, Nextech Invest, Ltd. made 8 notable position adjustments: 2 new positions were initiated, 4 existing holdings were added to, 1 positions were partially reduced, and 1 were completely exited. The largest of these moves: New buy: Cytomx Therapeutics INC (CTMX); Sold out: Mersana Therapeutics INC (MRSN); New buy: Corvus Pharmaceuticals INC (CRVS); Add: Alumis INC (ALMS) — shares +21.43%; Add: Engene Holdings INC — shares +9.41%
What sectors does Nextech Invest, Ltd. focus on?
Nextech Invest, Ltd. is concentrated in the following sectors based on its current disclosed equity portfolio:
• Health Care: 100.0%